Personalized Treatment of H3K27M-Mutant Pediatric Diffuse Gliomas Provides Improved Therapeutic Opportunities.

MLA

Gojo, Johannes, et al. “Personalized Treatment of H3K27M-Mutant Pediatric Diffuse Gliomas Provides Improved Therapeutic Opportunities.” Frontiers in Oncology, vol. 9, Jan. 2020, p. 1436. EBSCOhost, https://doi.org/10.3389/fonc.2019.01436.

APA

Gojo, J., Pavelka, Z., Zapletalova, D., Schmook, M. T., Mayr, L., Madlener, S., Kyr, M., Vejmelkova, K., Smrcka, M., Czech, T., Dorfer, C., Skotakova, J., Azizi, A. A., Chocholous, M., Reisinger, D., Lastovicka, D., Valik, D., Haberler, C., Peyrl, A., … Sterba, J. (2020). Personalized Treatment of H3K27M-Mutant Pediatric Diffuse Gliomas Provides Improved Therapeutic Opportunities. Frontiers in Oncology, 9, 1436. https://doi.org/10.3389/fonc.2019.01436

Chicago

Gojo, Johannes, Zdenek Pavelka, Danica Zapletalova, Maria T Schmook, Lisa Mayr, Sibylle Madlener, Michal Kyr, et al. 2020. “Personalized Treatment of H3K27M-Mutant Pediatric Diffuse Gliomas Provides Improved Therapeutic Opportunities.” Frontiers in Oncology 9 (January): 1436. doi:10.3389/fonc.2019.01436.